Position in TSHA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$194,445
-$44,805 QoQ
Shares Held
43,500
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST MANHATTAN CO. LLC. holds $4,696,275 across 10 Biotechnology names. TSHA ranks #4 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMAC |
DiaMedica Therapeutics Inc.
|
455,000 | $3,080,350 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,560 | $696,602 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
11,146 | $308,744 | |
| 4 | TSHA |
Taysha Gene Therapies, Inc.
This page
|
43,500 | $194,445 | |
| 5 | IMRX |
Immuneering Corp
|
24,245 | $127,771 | |
| 6 | IOVA |
Iovance Biotherapeutics, Inc.
|
28,998 | $101,782 | |
| 7 | ABUS |
Arbutus Biopharma Corp
|
14,000 | $63,000 | |
| 8 | ALDX |
Aldeyra Therapeutics, Inc.
|
34,745 | $58,719 |
All Filings in TSHA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,445 | 43,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $239,250 | 43,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $93,195 | 28,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $65,835 | 28,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $39,615 | 28,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $49,305 | 28,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||